Mao Inhibitors + Remibrutinib Interaction
Majorinteraction on record
Description
Concomitant use increases remibrutinib exposure and risk of adverse reactions. Avoid concomitant use.
Mechanism
Remibrutinib is a CYP3A4 substrate; inhibition increases exposure
Source: NLP:remibrutinib